{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:52:24Z","timestamp":1782921144722,"version":"3.54.5"},"reference-count":39,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100006083","name":"Ministry of Defence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dried plasma is an attractive option when provision of frozen plasma is challenging. FrontlineODP\u2122 system (Velico Medical) is a spray drying system producing a unit of spray dried plasma (SDP), in a blood bag, in around 30\u2009min. This study evaluates coagulation parameters before and after drying, using two types of starting plasma: Whole blood (WB) derived, and apheresis derived.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A minimum of 15 units each of WB derived CPD\u2010anticoagulated plasma and plasmapheresis (Aurora, Fresenius Kabi) sodium citrate\u2010anticoagulated plasma were sampled and frozen within 12\u201318\u2009h of venepuncture. Units were spray dried using the Velico FrontlineODP\u2122 system. Following rehydration with sterile water, further samples were taken. All samples (pre drying, immediately post rehydration and 6\u2009h post rehydration) were tested in parallel for a range of coagulation parameters, including thrombin generation, as well as biochemical parameters and bacterial contamination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All dried plasma units rehydrated in an average of 6\u2009min. All coagulation parameters were within \u00b120% pre to post drying, except von Willebrand factor (vWF) activity and FXIII activity, which decreased by approximately 50% and 25%, respectively. Further investigation of vWF showed a change in the ratio of high and low molecular weight multimers. No bacterial contamination was detected in any of the units.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary\/Conclusions<\/jats:title>\n                    <jats:p>The FrontlineODP system can be incorporated into a standard blood service laboratory environment and successfully produce SDP with acceptable levels of coagulation proteins. Clinical data assessing SDP in a relevant patient population are now needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/trf.70219","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:29:21Z","timestamp":1782919761000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spray dried plasma manufactured from apheresis and whole blood derived plasma"],"prefix":"10.1111","author":[{"given":"Lucy","family":"Bower","sequence":"first","affiliation":[{"name":"Component Development Laboratory NHS Blood and Transplant  Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-554X","authenticated-orcid":false,"given":"Sian","family":"Huish","sequence":"additional","affiliation":[{"name":"Component Development Laboratory NHS Blood and Transplant  Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Oleniacz","sequence":"additional","affiliation":[{"name":"Component Development Laboratory NHS Blood and Transplant  Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ellington","sequence":"additional","affiliation":[{"name":"Department of Haematology University of Cambridge  Cambridge UK"},{"name":"Academic Department of Military Emergency Medicine Royal Centre for Defence Medicine  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2131-2281","authenticated-orcid":false,"given":"Melanie J.","family":"Robbins","sequence":"additional","affiliation":[{"name":"Component Development Laboratory NHS Blood and Transplant  Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Woolley","sequence":"additional","affiliation":[{"name":"Academic Department of Military Anaesthesia and Critical Care Research &amp; Clinical Innovation  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihae","family":"Sohn","sequence":"additional","affiliation":[{"name":"Velico Medical  Beverly Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Green","sequence":"additional","affiliation":[{"name":"Centre for Trauma Sciences, Blizard Institute Queen Mary University of London  London UK"},{"name":"NHS Blood and Transplant  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cardigan","sequence":"additional","affiliation":[{"name":"Component Development Laboratory NHS Blood and Transplant  Cambridge UK"},{"name":"Department of Haematology University of Cambridge  Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"2","key":"e_1_2_10_2_1","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2019.5085","article-title":"Association of Prehospital Plasma Transfusion with Survival in trauma patients with hemorrhagic shock when transport times are longer than 20 minutes: a post hoc analysis of the PAMPer and COMBAT clinical trials","volume":"155","author":"Pusateri AE","year":"2020","journal-title":"JAMA Surg"},{"issue":"18","key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMc1811315","article-title":"Prehospital plasma during air medical transport in trauma patients","volume":"379","author":"Sperry JL","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jss.2013.05.086","article-title":"Initial assessment on the impact of crystalloids versus colloids during damage control resuscitation","volume":"185","author":"Guidry C","year":"2013","journal-title":"J Surg Res"},{"issue":"1","key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13054-022-04279-4","article-title":"Association of red blood cells and plasma transfusion versus red blood cell transfusion only with survival for treatment of major traumatic hemorrhage in prehospital setting in England: a multicenter study","volume":"27","author":"Tucker H","year":"2023","journal-title":"Crit Care"},{"issue":"16","key":"e_1_2_10_6_1","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.2017.15097","article-title":"Association of prehospital blood product transfusion during medical evacuation of combat casualties in Afghanistan with acute and 30\u2212day survival","volume":"318","author":"Shackelford SA","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"e_1_2_10_7_1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/trf.15261","article-title":"The need for dried plasma\u2014a national issue","volume":"59","author":"Pusateri AE","year":"2019","journal-title":"Transfusion"},{"key":"e_1_2_10_8_1","volume-title":"Fresh frozen plasma, leucocyte depleted [Internet]","author":"Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee","year":"2025"},{"issue":"4","key":"e_1_2_10_9_1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/trf.13915","article-title":"A paired comparison of thawed and liquid plasma","volume":"57","author":"Backholer L","year":"2017","journal-title":"Transfusion"},{"issue":"4","key":"e_1_2_10_10_1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00000658-194004000-00013","article-title":"The intravenous use of serum and plasma, fresh and preserved","volume":"111","author":"Strumia MM","year":"1940","journal-title":"Ann Surg"},{"issue":"4","key":"e_1_2_10_11_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmrv.2025.150931","article-title":"TMR paper for issue on \u201cTechnologies in Transfusion Medicine\u201d dried plasma\u2014where are we and where next?","volume":"39","author":"Ellington M","year":"2025","journal-title":"Transfus Med Rev"},{"issue":"2","key":"e_1_2_10_12_1","first-page":"707","article-title":"Single\u2212donor spray\u2212dried plasma","volume":"59","author":"Liu QP","year":"2019","journal-title":"Transfusion"},{"issue":"3","key":"e_1_2_10_13_1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0049-3848(82)90248-1","article-title":"Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein \u201clike\u201d activity in human plasma","volume":"25","author":"Gallimore MJ","year":"1982","journal-title":"Thromb Res"},{"key":"e_1_2_10_14_1","unstructured":"FDA.Octaplas.https:\/\/www.fda.gov\/media\/123132\/download"},{"issue":"6","key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1538-7836.2012.04729.x","article-title":"Differential sensitivity of von Willebrand factor (VWF) \u2018activity\u2019 assays to large and small VWF molecular weight forms: a cross\u2212laboratory study comparing ristocetin cofactor, collagen\u2212binding and mAb\u2212based assays","volume":"10","author":"Favaloro EJ","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"4","key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pathol.2016.03.001","article-title":"Laboratory tests used to help diagnose von Willebrand disease: an update","volume":"48","author":"Favaloro EJ","year":"2016","journal-title":"Pathology"},{"issue":"2","key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/trf.15038","article-title":"Spray\u2212dried plasma deficient in high\u2212molecular\u2212weight multimers of von Willebrand factor retains hemostatic properties","volume":"59","author":"Meledeo MA","year":"2019","journal-title":"Transfusion"},{"issue":"6","key":"e_1_2_10_18_1","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/trf.15856","article-title":"Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity","volume":"60","author":"Dyer MR","year":"2020","journal-title":"Transfusion"},{"issue":"3","key":"e_1_2_10_19_1","first-page":"S158","article-title":"Von Willebrand factor as a thrombotic and inflammatory mediator in critical illness","volume":"60","author":"Plautz WE","year":"2020","journal-title":"Transfusion"},{"issue":"5","key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/trf.12431","article-title":"Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy","volume":"54","author":"Levy JH","year":"2014","journal-title":"Transfusion"},{"issue":"4","key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2352-3026(22)00040-0","article-title":"Resuscitation with blood products in patients with trauma\u2212related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open\u2212label, randomised, controlled, phase 3 trial","volume":"9","author":"Crombie N","year":"2022","journal-title":"Lancet Haematol"},{"issue":"10144","key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(18)31553-8","article-title":"Plasma\u2212first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial","volume":"392","author":"Moore HB","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"e_1_2_10_23_1","first-page":"13A","article-title":"Abstract information: spray\u2212dried plasma: a multi\u2212center, prospective, randomized, dose\u2212escalation CohortSafety clinical trial","volume":"65","author":"M P","year":"2025","journal-title":"Transfusion"},{"issue":"3","key":"e_1_2_10_24_1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1537-2995.2011.03300.x","article-title":"Changes in coagulation factor activity and content of di(2\u2212ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing","volume":"52","author":"Sheffield WP","year":"2012","journal-title":"Transfusion"},{"issue":"8","key":"e_1_2_10_25_1","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1537-2995.2009.02198.x","article-title":"Evaluation and comparison of coagulation factor activity in fresh\u2212frozen plasma and 24\u2212hour plasma at thaw and after 120 hours of 1 to 6 degrees C storage","volume":"49","author":"Scott E","year":"2009","journal-title":"Transfusion"},{"issue":"11","key":"e_1_2_10_26_1","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1111\/trf.15549","article-title":"Effect of storage of plasma in the presence of red blood cells and platelets: re\u2212evaluating the shelf life of whole blood","volume":"59","author":"Huish S","year":"2019","journal-title":"Transfusion"},{"issue":"1","key":"e_1_2_10_27_1","first-page":"S98","article-title":"Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35\u2212day cold\u2212storage regardless of leukoreduction timing","volume":"62","author":"Schubert P","year":"2022","journal-title":"Transfusion"},{"issue":"1","key":"e_1_2_10_28_1","first-page":"S204","article-title":"Extended storage of leukoreduced whole blood for transfusion stored in CPD from 21 to 35\u2009days to improve prehospital blood supply logistics in rural areas","volume":"65","author":"Braathen H","year":"2025","journal-title":"Transfusion"},{"issue":"7","key":"e_1_2_10_29_1","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/vox.12825","article-title":"An in vitro study of coagulation properties in refrigerated whole blood and reconstituted whole blood","volume":"114","author":"Wang S","year":"2019","journal-title":"Vox Sang"},{"issue":"6","key":"e_1_2_10_30_1","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/TA.0000000000001896","article-title":"Preparation of leukoreduced whole blood for transfusion in austere environments; effects of forced filtration, storage agitation, and high temperatures on hemostatic function","volume":"84","author":"Sivertsen J","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"e_1_2_10_31_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1423-0410.2004.00552.x","article-title":"Stability of coagulation factors in thawed, solvent\/detergent\u2212treated plasma during storage at 4 degrees C for 6\u2009days","volume":"87","author":"Buchta C","year":"2004","journal-title":"Vox Sang"},{"issue":"2","key":"e_1_2_10_32_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.transci.2012.01.005","article-title":"Clotting factor activity in thawed Octaplas(R) LG during storage at 2\u22126 degrees C for 6\u2009days from a quality assurance point of view","volume":"46","author":"Keller MK","year":"2012","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"e_1_2_10_33_1","first-page":"360","article-title":"Thawed solvent\/detergent\u2212treated plasma: too precious to be wasted after 6 hours?","volume":"10","author":"Keller MK","year":"2012","journal-title":"Blood Transfus"},{"issue":"11","key":"e_1_2_10_34_1","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1111\/trf.15533","article-title":"Freeze\u2212dried plasma stability under prehospital field conditions","volume":"59","author":"Zur M","year":"2019","journal-title":"Transfusion"},{"issue":"12","key":"e_1_2_10_35_1","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1111\/trf.12191","article-title":"Quality of freeze\u2212dried (lyophilized) quarantined single\u2212donor plasma","volume":"53","author":"Bux J","year":"2013","journal-title":"Transfusion"},{"key":"e_1_2_10_36_1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/vox.13798","article-title":"An experimental comparison and user evaluation of three different dried plasma products","volume":"120","author":"Ehn K","year":"2025","journal-title":"Vox Sang"},{"issue":"2","key":"e_1_2_10_37_1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ALN.0b013e3182608cdd","article-title":"In vitro hemostatic properties of French lyophilized plasma","volume":"117","author":"Martinaud C","year":"2012","journal-title":"Anesthesiology"},{"issue":"1","key":"e_1_2_10_38_1","first-page":"65S","article-title":"The evolving role of lyophilized plasma in remote damage control resuscitation in the French armed forces health service","volume":"53","author":"Sailliol A","year":"2013","journal-title":"Transfusion"},{"key":"e_1_2_10_39_1","unstructured":"FDA.Fact Sheet for Health Care Professionals or Other Authorized Providers\u2212octaplasLG Powder. Available from:https:\/\/www.fda.gov\/media\/180724\/download"},{"issue":"2","key":"e_1_2_10_40_1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/trf.13356","article-title":"Five\u2212day stability of thawed plasma: solvent\/detergent\u2212treated plasma comparable with fresh\u2212frozen plasma and plasma frozen within 24 hours","volume":"56","author":"Neisser\u2212Svae A","year":"2016","journal-title":"Transfusion"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70219","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.70219","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:29:38Z","timestamp":1782919778000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.70219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":39,"alternative-id":["10.1111\/trf.70219"],"URL":"https:\/\/doi.org\/10.1111\/trf.70219","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"2026-01-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"trf.70219"}}